skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Adult remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Activity and safety of brigatinib in ALK -rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Activity and safety of brigatinib in ALK -rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Activity and safety of brigatinib in ALK -rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial

Gettinger, Scott N, Dr ; Bazhenova, Lyudmila A, Prof ; Langer, Corey J, Prof ; Salgia, Ravi, Prof ; Gold, Kathryn A, MD ; Rosell, Rafael, Prof ; Shaw, Alice T, MD ; Weiss, Glen J, MD ; Tugnait, Meera, PhD ; Narasimhan, Narayana I, PhD ; Dorer, David J, PhD ; Kerstein, David, MD ; Rivera, Victor M, PhD ; Clackson, Timothy, PhD ; Haluska, Frank G, MD ; Camidge, David Ross, Prof

The lancet oncology, 2016-12, Vol.17 (12), p.1683-1696 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery
The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery

Johnson, Mark P., MD ; Bennett, Kelly A., MD ; Rand, Larry, MD ; Burrows, Pamela K., MS ; Thom, Elizabeth A., PhD ; Howell, Lori J., RN, PhD ; Farrell, Jody A., RN, MSN ; Dabrowiak, Mary E., RN, MSN ; Brock, John W., MD ; Farmer, Diana L., MD ; Adzick, N. Scott, MD

American journal of obstetrics and gynecology, 2016-12, Vol.215 (6), p.778.e1-778.e9 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial

Camidge, D Ross ; Kim, Hye Ryun ; Ahn, Myung-Ju ; Yang, James C H ; Han, Ji-Youn ; Hochmair, Maximilian J ; Lee, Ki Hyeong ; Delmonte, Angelo ; García Campelo, Maria Rosario ; Kim, Dong-Wan ; Griesinger, Frank ; Felip, Enriqueta ; Califano, Raffaele ; Spira, Alexander ; Gettinger, Scott N ; Tiseo, Marcello ; Lin, Huamao M ; Gupta, Neeraj ; Hanley, Michael J ; Ni, Quanhong ; Zhang, Pingkuan ; Popat, Sanjay

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3592-3603 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Herbst, Roy S ; Soria, Jean-Charles ; Kowanetz, Marcin ; Fine, Gregg D ; Hamid, Omid ; Gordon, Michael S ; Sosman, Jeffery A ; McDermott, David F ; Powderly, John D ; Gettinger, Scott N ; Kohrt, Holbrook E K ; Horn, Leora ; Lawrence, Donald P ; Rost, Sandra ; Leabman, Maya ; Xiao, Yuanyuan ; Mokatrin, Ahmad ; Koeppen, Hartmut ; Hegde, Priti S ; Mellman, Ira ; Chen, Daniel S ; Hodi, F Stephen

Nature (London), 2014-11, Vol.515 (7528), p.563-567 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes
The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes

Farmer, Diana L. ; Thom, Elizabeth A. ; Brock, John W. ; Burrows, Pamela K. ; Johnson, Mark P. ; Howell, Lori J. ; Farrell, Jody A. ; Gupta, Nalin ; Adzick, N. Scott

American journal of obstetrics and gynecology, 2018-02, Vol.218 (2), p.256.e1-256.e13 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Cardiac tamponade as a life-threatening complication in hernia repair
Cardiac tamponade as a life-threatening complication in hernia repair
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cardiac tamponade as a life-threatening complication in hernia repair

Frantzides, Constantine T., MD, PhD, FACS ; Welle, Scott N., DO

Surgery, 2012-07, Vol.152 (1), p.133-135 [Periódico revisado por pares]

New York, NY: Mosby, Inc

Texto completo disponível

Citações Citado por
7
Bladder Function After Fetal Surgery for Myelomeningocele
Bladder Function After Fetal Surgery for Myelomeningocele
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bladder Function After Fetal Surgery for Myelomeningocele

Brock, 3rd, John W ; Carr, Michael C ; Adzick, N Scott ; Burrows, Pamela K ; Thomas, John C ; Thom, Elizabeth A ; Howell, Lori J ; Farrell, Jody A ; Dabrowiak, Mary E ; Farmer, Diana L ; Cheng, Earl Y ; Kropp, Bradley P ; Caldamone, Anthony A ; Bulas, Dorothy I ; Tolivaisa, Susan ; Baskin, Laurence S

Pediatrics (Evanston), 2015-10, Vol.136 (4), p.e906-e913 [Periódico revisado por pares]

United States: American Academy of Pediatrics

Texto completo disponível

Citações Citado por
8
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)

Diab, Adi ; Tannir, Nizar M ; Bentebibel, Salah-Eddine ; Hwu, Patrick ; Papadimitrakopoulou, Vassiliki ; Haymaker, Cara ; Kluger, Harriet M ; Gettinger, Scott N ; Sznol, Mario ; Tykodi, Scott S ; Curti, Brendan D ; Tagliaferri, Mary A ; Zalevsky, Jonathan ; Hannah, Alison L ; Hoch, Ute ; Aung, Sandra ; Fanton, Christie ; Rizwan, Ahsan ; Iacucci, Ernesto ; Liao, Yijie ; Bernatchez, Chantale ; Hurwitz, Michael E ; Cho, Daniel C

Cancer discovery, 2020-08, Vol.10 (8), p.1158-1173

United States

Texto completo disponível

Citações Citado por
9
Surgical management of pediatric thyroid disease: Complication rates after thyroidectomy at the Children's Hospital of Philadelphia high-volume Pediatric Thyroid Center
Surgical management of pediatric thyroid disease: Complication rates after thyroidectomy at the Children's Hospital of Philadelphia high-volume Pediatric Thyroid Center
Material Type:
Artigo 		Adicionar ao Meu Espaço

Surgical management of pediatric thyroid disease: Complication rates after thyroidectomy at the Children's Hospital of Philadelphia high-volume Pediatric Thyroid Center

Baumgarten, Heron D. ; Bauer, Andrew J. ; Isaza, Amber ; Mostoufi-Moab, Sogol ; Kazahaya, Ken ; Adzick, N. Scott

Journal of pediatric surgery, 2019-10, Vol.54 (10), p.1969-1975 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

Gettinger, Scott N ; Horn, Leora ; Gandhi, Leena ; Spigel, David R ; Antonia, Scott J ; Rizvi, Naiyer A ; Powderly, John D ; Heist, Rebecca S ; Carvajal, Richard D ; Jackman, David M ; Sequist, Lecia V ; Smith, David C ; Leming, Philip ; Carbone, David P ; Pinder-Schenck, Mary C ; Topalian, Suzanne L ; Hodi, F Stephen ; Sosman, Jeffrey A ; Sznol, Mario ; McDermott, David F ; Pardoll, Drew M ; Sankar, Vindira ; Ahlers, Christoph M ; Salvati, Mark ; Wigginton, Jon M ; Hellmann, Matthew D ; Kollia, Georgia D ; Gupta, Ashok K ; Brahmer, Julie R

Journal of clinical oncology, 2015-06, Vol.33 (18), p.2004-2012 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (4.497)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (4.709)
  2. Anais de Congresso  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1976  (34)
  2. 1976Até1987  (193)
  3. 1988Até1999  (770)
  4. 2000Até2012  (1.851)
  5. Após 2012  (1.863)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (4.709)
  2. Japonês  (806)
  3. Francês  (6)
  4. Italiano  (4)
  5. Norueguês  (4)
  6. Alemão  (3)
  7. Chinês  (2)
  8. Russo  (1)
  9. Português  (1)
  10. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.